Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Issued: 2018-2025

Historic Shares Issued for Bicycle Therapeutics (BCYC) over the last 6 years, with Sep 2025 value amounting to $1,000.

  • Bicycle Therapeutics' Shares Issued rose 100.10% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$975,000, marking a year-over-year decrease of 100.18%. This contributed to the annual value of $544.1 million for FY2024, which is 118.22% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Shares Issued stood at $1,000, which was down 0.00% from $1,000 recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Shares Issued ranged from a high of $543.2 million in Q2 2024 and a low of -$979,000 during Q3 2024.
  • Moreover, its 3-year median value for Shares Issued was $940,500 (2023), whereas its average is $79.3 million.
  • In the last 5 years, Bicycle Therapeutics' Shares Issued soared by 2,938,650.00% in 2021 and then plummeted by 100.42% in 2024.
  • Bicycle Therapeutics' Shares Issued (Quarterly) stood at $188.4 million in 2021, then crashed by 97.40% to $4.9 million in 2022, then plummeted by 99.80% to $10,000 in 2023, then crashed by 100.42% to -$979,000 in 2024, then spiked by 100.10% to $1,000 in 2025.
  • Its last three reported values are $1,000 in Q3 2025, $1,000 for Q2 2025, and $2,000 during Q1 2025.